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Trafficking of water channel aquaporin-2 (AQP2) to the apical membrane is critical to water reabsorption in renal collecting ducts and its
regulation maintains body water homeostasis. However, exact molecular mechanisms which recruit AQP2 are unknown. Recent studies
highlighted a key role for spatial and temporal regulation of actin dynamics in AQP2 trafficking. We have recently identified AQP2-binding
proteins which directly regulate this trafficking: SPA-1, a GTPase-activating protein (GAP) for Rap1, and cytoskeletal protein actin. In addition, a
multiprotein “force generator” complex which directly binds to AQP2 has been discovered. This review summarizes recent advances related to the
mechanism for AQP2 trafficking.
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duct. Key components in the regulation of collecting duct water
permeability are vasopressin receptor and water channel
aquaporin-2 (AQP2) [1–4]. Upon vasopressin stimulation,
AQP2 translocates from intracellular storage vesicles to the
apical plasma membrane, rendering the cell water permeable,
which in turn causes water reabsorption leading to urine con-
centration [5–7]. AQP2 mutations cause congenital nephro-⁎ Corresponding author. Tel.: +81 3 5803 5214; fax: +81 3 5803 5215.
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doi:10.1016/j.bbamem.2006.03.004genic diabetes insipidus (NDI), a disease characterized by a
massive loss of water through the kidney [8–22]. In this review,
we focus on the AQP2 trafficking and AQP2-binding proteins.
1. The cAMP-mediated effect of vasopressin on AQP2
trafficking
In response to an increase in serum osmolarity and a
reduction in effective circulating blood volume, osmoreceptors
located in the hypothalamus are activated and stimulate the
secretion of antidiuretic hormone arginine vasopressin from the
posterior pituitary [23,24]. After released systemically,
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on the baso lateral membrane of the renal collecting duct
principal cells [25]. The V2R is coupled to adenylate cyclase by
the heterotrimeric G-protein, Gs. Gs is a guanosine triphosphate
(GTP)-binding protein which consists of three subunits: α, β,
and γ. The binding of vasopressin to its receptor causes the α
subunit to release guanosine diphosphate (GDP), bind to GTP,
and dissociate from the β and γ subunits. This G α–GTP
complex, in turn, activates adenylate cyclase which catalyzes
the conversion of ATP to cyclic adenosine monophosphate
(cAMP). The subsequent activation of protein kinase A (PKA)
leads to phosphorylation of AQP2 at serine 256 [26–30]. This
phosphorylation event is required for AQP2 translocation from
intracellular storage vesicles to the apical membrane which
causes an increase in water permeability of renal principal cells.
The increase in permeability allows water to flow from the
tubule lumen to the hypertonic medullary interstitium. This then
leads to the formation of concentrated urine. Withdrawal of
vasopressin triggers the endocytosis of AQP2-containing
vesicles and restores the water-impermeable state of the apical
membrane. In this process, AQP2 on the plasma membrane is
first retrieved to EEA1-positive early endosomes, and then
transferred to Rab11-positive storage vesicles [31].
AQP2 forms homotetramer and for a plasma membrane
localization at least three out of four monomers in an AQP2
tetramer have to be phosphorylated [19,32,33].
PKA phosphorylation of AQP2 at serine 256 is important for
AQP2 trafficking as described above. In addition, it is reported
that cAMP-dependent phosphorylation of AQP2 increased
membrane water permeability (Pf) of oocytes expressing wild-
type AQP2 but did not increased Pf of oocytes expressing the
nonphosphorylatable mutant AQP2-S256A, whereas the
amounts of wild and mutant AQP2 expression on the oocyte
membrane were similar [34]. This finding indicates that PKA
phosphorylation increases water permeability of AQP2 protein.
On the contrary, using AQP2-containing endosomes derived
from inner medullary collecting duct (IMCD), it is shown that
PKA phosphorylation does not alter Pf of the AQP2-containing
endosomes [35]. The effect of PKA phosphorylation of AQP2
on permeability of AQP2 water channel protein remains to be
investigated directly.
As PKA and many of its substrates are present throughout
the cell, localization of PKA to specific sites is necessary for a
timely and spatially effective activation of PKA. This process is
mediated by protein kinase A anchoring proteins (AKAPs)
which tether PKA to specific sites and limit its access to a subset
of substrates [36–38]. Lande et al. found that AQP2-bearing
vesicles contained PKA activity [35]. The anchoring of PKA to
AKAPs was demonstrated to be a prerequisite for the AQP2
shuttle using the membrane-permeable anchoring inhibitor
peptide S-Ht31 [39–41]. Henn et al. found that a new splice
variant of AKAP18, AKAP18δ, was involved in this AQP2
shuttle [42].
However, the precise role of AQP2 phosphorylation in AQP2
trafficking still remains to be established. Recent work has
demonstrated that the serine/threonine phosphatase inhibitor
okadaic acid induces AQP2 translocation even in the presence ofH89, a specific PKA inhibitor [43]. In addition, phosphoryla-
tion-deficient AQP2 mutant S256A accumulates at the plasma
membrane by GTPase-deficient dynamin mutant or cholesterol-
depleting agent [44]. Thus, AQP2 translocation may involve a
mechanism which is independent of PKA phosphorylation in
renal collecting-duct cells.
While PKA phosphorylation is required for the vasopressin-
induced cell-surface accumulation of AQP2, dephosphorylation
of AQP2 is not necessary for its subsequent internalization.
Prostaglandin E2 stimulates removal of AQP2 from the surface
of principal cells when added after vasopressin treatment but
does not alter the phosphorylated state of AQP2 [30]. In
addition, it is reported that both Prostaglandin E2 and dopamine
induce internalization of AQP2 independently of AQP2
dephosphorylation in MDCK cells transfected with AQP2 [45].
2. Role of calcium in AQP2 trafficking
Several studies have provided evidences for a role of intra-
cellular Ca2+ mobilization in vasopressin-mediated AQP-2 traf-
ficking. In addition to increasing cAMP levels in collecting duct
principal cells, vasopressin binding to the V2 receptor was also
demonstrated to trigger a rapid increase of intracellular Ca2+,
followed by sustained oscillations [46–50]. Pre-incubating the
isolated IMCD cells with an intracellular Ca2+ chelator
prevented vasopressin-induced intracellular Ca2+ mobilization,
apical exocytosis, and increase of osmotic water permeability.
Both ryanodine and calmodulin inhibitors were shown to block
vasopressin-stimulated translocation of AQP-2 to the plasma
membrane [51,52]. Removal of extracellular Ca2+ in perfused
IMCD did not prevent the initial rise of intracellular Ca2+
induced by vasopressin but inhibited the sustained oscillations
[50]. These findings suggest that the vasopressin-induced Ca2+
increase and oscillations are important for AQP2 translocation to
the apical membrane, and involve intracellular Ca2+ released
from ryanodine-sensitive stores and the influx of extracel-
lular Ca2+.
In contrast with the findings as described above, Lorenz et al.
showed that intracellular Ca2+ was not able to promote or evoke
the AQP2 shuttle in primary cultured IMCD cells [53]. AQP2
trafficking was not promoted by increasing intracellular Ca2+
concentrations. Vasopressin-induced AQP2 redistribution to the
plasma membrane was fully preserved even in the cases that
intracellular Ca2+ concentrations were clamped at both 50 nM
and 150 nM. Only clamping at 25 nM abolished the AQP2
trafficking, indicating a requirement of Ca2+ at a very low level.
An intracellular Ca2+ chelator did not reduce forskolin-elicited
Pf increment.
The discrepancy in the effect of intracellular Ca2+ on AQP2
trafficking may be caused by the different kinds of experimental
systems. Further studies are required for clarifying the role of
intracellular Ca2+ mobilization in AQP2 trafficking.
Extracellular Ca2+ is also known to be involved in AQP2
regulation. Urinary AQP2 correlates with the severity of enure-
sis, a disease characterized by nocturnal polyuria and hyper-
calciuria [54]. Clinical amelioration demonstrated by a low
calcium diet is accompanied by regulation of urine output
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Drug-induced hypercalcemia/hypercalciuria causes polyuria
and reduces AQP2 expression in rats [56]. Procino et al.
showed that extracellular Ca2+ inhibited forskolin-induced
AQP2 translocation to the apical membrane, possibly acting
through calcium-sensing receptor signaling [57]. In this process,
PKC activation, decrease in forskolin-elicited cAMP increment
and increase in F-actin were observed.
3. Phosphorylation by the other kinases
Phosphorylation of AQP2 by not only PKA but the other
kinases may potentially participate in regulation of AQP2
trafficking. Besides PKA sites, putative phosphorylation sites
for PKG, PKC, and casein kinase II are also present in the
AQP2 sequence. Serine 256 is also a substrate for Golgi casein
kinase. It is reported that AQP2 transition in the Golgi apparatus
is associated with a PKA-independent increase in AQP2 phos-
phorylation at serine 256, suggesting that phosphorylation by
Golgi casein kinase may be required for Golgi transition [58]. In
addition, activation of PKC pathway was shown to mediate
endocytosis of AQP2 which was independent of the phosphor-
ylation state of this water channel at serine 256 [26].
Phosphorylation of other cytoplasmic or vesicular regulatory
proteins may also be involved. This issue remains to be
investigated directly.
Other alternative (or parallel) trafficking pathways are also
being uncovered. Bouley et al. have shown that nitric oxide and
atrial natriuretic factor stimulate the insertion of AQP2 in renal
epithelial cells via a cGMP-dependent pathway [59]. In addi-
tion, it is reported that cGMP phosphodiesterase inhibitor
sildenafil citrate (Viagra) induced AQP2 membrane insertion
[60]. It is not yet clear whether PKG directly phosphorylates
AQP2 or whether the cGMP/PKG effect is ultimately mediated
by activation of PKA.
4. Role of the cytoskeleton in AQP2 trafficking
The physiological properties within the cell differ signifi-
cantly from conditions in aqueous solution. The large number of
subcellular structures, organelles and macromolecules creates a
crowded environment. In addition, cells contain significant
mass percentages of protein, which sometimes exceed one
quarter of their weight. The large proportion of proteins in the
cytoplasm implies that their intracellular distribution more
closely resembles a protein crystal than a protein solution [61].
Although diffusion can be the principal mechanism of molec-
ular movement on a ∼20 nm scale, movement over greater
distances cannot occur simply through diffusion [62]. It has
become clear that the microtubules and actin cytoskeletons act
coordinately to regulate trafficking of many membrane proteins
[63,64]. In the case of AQP2, the microtubules and actin
cytoskeletons are also essential in its trafficking, and it has been
generally believed that the coordinated and strictly regulated
AQP2 trafficking therefore requires organized dynamics of the
cytoskeleton and its associated proteins. Indeed, Proteomic
analyses showed that both AQP2-bearing vesicles from IMCDand AQP2-containing exosomes isolated from urine contained
cytoskeletal proteins and its associated proteins [65,66].
Even before the discovery of AQP2, several papers described
that microtubular network was involved in regulation of water
permeability of collecting tubules by vasopressin [67–69].
Microtubules are polar structures, arising from microtubule
organizing centers (MTOCs), at which their minus ends are
anchored, and with the plus ends growing into the cell. Dynein
is shown to be present in the kidney and both dynein and
dynactin, a protein complex believed to mediate the interaction
of dynein with vesicles, associate with AQP2-bearing vesicles
[70]. Both vanadate, an inhibitor of ATPases, and erythro-9-
(2-hydroxy-3-nonyl) adenine (EHNA), an inhibitor of dynein,
inhibit the antidiuretic response in toad bladder [71,72]. Thus,
the microtubule-associated motor protein dynein and dynactin
are important in vasopressin-regulated trafficking of AQP2-
bearing vesicles.
A reorganization of actin cytoskeleton has also been shown
to be essential in the trafficking of AQP2-containing vesicles. It
has been suggested that the actin cytoskeleton provides a
network that anchors the AQP2-bearing vesicles in the un-
stimulated cell and that a reorganization of the apical actin
network may be critical in promoting the trafficking of AQP2-
bearing vesicles. Indeed, vasopressin has been shown to depo-
lymerize apical F-actin in rat inner medullary collecting duct,
resulting in the fusion of water channel-carrying vesicles with
the apical membrane [73]. Both forskolin and okadaic acid
stimulate AQP-2 translocation by inducing a reorganization of
the apical actin network [43]. Recent studies showed that actin
depolymerization was a prerequisite for cAMP-dependent
translocation of AQP2 and inhibition of small GTPase Rho
induced this translocation by causing actin depolymerization
[74,75]. These data provide strong evidence for a major
regulatory role of the actin depolymerization in the vasopres-
sin-induced recycling of AQP2 between intracellular vesicles
and the cell surface.
Furthermore, RhoA inhibition through PKA-mediated phos-
phorylation of RhoA is shown to be a key event for actin
dynamics inducing AQP2 translocation [76]. In addition,
Tamma et al. showed that stimulation of prostaglandin E3
receptors inhibited vasopressin-induced Rho inactivation,
vasopressin-induced F-actin depolymerization, and vasopres-
sin-, cAMP - and forskolin-induced AQP2 translocation [77].
Bradykinin is shown to increase Rho activity, resulting in
cortical F-actin stabilization and impairment of AQP2 traffick-
ing [78]. Ezrin/radixin/moesin (ERM) proteins cross-link actin
filaments with the plasma membrane and it is reported that
moesin is involved in AQP2 apical targeting by inducing actin
depolymerization [79].
Actin depolymerization is shown to be important for AQP2
trafficking as described above. On the contrary, it is reported
that actin-depolymerizing agent cytochalasin D did not enhance
water permeability of the epithelium of toad urinary bladder
[80]. The authors speculate that F-actin had at least two hypo-
thetical pools: one is involved in the barrier function and the
other pool is involved in migration of AQP2 from diverse
regions of cytoplasm to the subapical region. In addition, it is
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phosphorylation which is known to result in an enhancement of
myosin-actin filament interaction and the formation of actin
fibers [81].
Tajika et al. showed that actin depolymerization caused by
cytochalasin D or latrunculin B induced AQP2 accumulation in
EEA1-positive early endosomes, indicating that actin filaments
were required for the transfer of AQP2 from the early endo-
somes to Rab11-positive subapical storage vesicles [82]. The
authors also showed that actin depolymerization induced the
retrieval of AQP2 from the apical plasma membrane even in
the presence of forskolin.
Cytoskeleton-modulating agents inevitably affect the overall
cell architecture at least to a small extent which makes the
experiments examining the role of actin in AQP2 trafficking
difficult. It is speculated that in the process that the physiological
trafficking of AQP2 occurs in vivo, the actin dynamics may
change in a restricted narrow area around AQP2 molecule and
may vary among different areas within the cell.
5. Fusion of AQP2 vesicles with the apical membrane
The molecular machinery for the docking and fusion of
AQP2-containing vesicles with the apical membrane has some
similarity to the process of synaptic vesicle fusion with
the presynaptic membrane and involves vesicle (v) SNAREs
(soluble NSF attachment protein receptors) and target mem-
brane (t) SNAREs. vSNAREs such as VAMP-2 (vesicle-
associated membrane polypeptide-2) are present in the collect-
ing duct principal cells and colocalize with AQP2 in the same
vesicles [83–85]. Treatment with tetanus toxin, which cleaves
the SNARE protein VAMP-2/synaptobrevin, abolishes vaso-
pressin-induced AQP2 translocation to the plasma membrane
[86]. The tSNARE syntaxin 4 is present in the apical plasma
membrane of collecting duct principal cells [87,88]. Another
tSNARE, SNAP23 (soluble N-ethylmaleimide-associated pro-
tein), has also been found in collecting duct principal cells both
in the apical membrane and in AQP2-bearing vesicles [89]. In-
vitro studies have revealed that SNAP-23 bound to syntaxin-4
and VAMP-2 [90]. However, another study reported that the
localization of SNAP-23 was different from AQP2 [91]. In
addition to SNARE proteins, heterotrimeric GTP binding
proteins of the Gi family are also involved in the AQP2
shuttling and/or fusion process [92].
6. Endocytosis
During the endocytotic process of AQP2 recycling pathway,
AQP2 accumulates in clathrin-coated pits and is internalized via
a clathrin-mediated process [93–96]. Recent studies showed
that AQP2 accumulated on the plasma membrane in a vaso-
pressin-independent manner when clathrin-mediated endocyto-
sis was inhibited by dominant-negative, GTPase-deficient
K44A dynamin [96]. Dynamin is a GTPase that is involved in
the formation and pinching off of clathrin-coated pits to form
clathrin-coated vesicles [97–99]. The dominant-negative form
has a point mutation, K44A, that renders the protein GTPasedeficient and arrests clathrin-mediated endocytosis [99–101].
Phosphorylation-deficient mutant AQP2-S256A accumulates at
the plasma membrane by the GTPase-deficient dynamin mutant
K44A or methyl-β-cyclodextrin [44]. This drug depletes
membranes of cholesterol and results in a rapid inhibition of
endocytosis. An extensive accumulation of AQP2 at the cell
surface has been accomplished within 15 min after inhibition of
endocytosis by treatment with methyl-β-cyclodextrin. These
data indicate that AQP2 recycles constitutively and rapidly
between intracellular stores and the cell surface and the
constitutive trafficking process is not dependent on phosphor-
ylation of AQP2 at serine 256.
7. Impaired trafficking of mutant AQP2 causes
nephrogenic diabetes insipidus
Mutations in AQP2 cause congenital nephrogenic diabetes
insipidus (NDI), a disease characterized by an inability to
concentrate urine despite normal or elevated plasma concentra-
tions of vasopressin, resulting in a massive loss of water through
the kidney. AQP2 mutant proteins are misrouted and cannot be
localized at the luminal membrane. To date, 35 mutations in
AQP2 have been reported. There are two inheritance types:
most common autosomal-recessive type and less common
autosomal-dominant type. Recessive mutations cause misfold-
ing of the protein and retention in the endoplasmic reticulum
(ER) [8–16]. Dominant mutations cause retention of AQP2 in
the Golgi complex, late endosomes/lysosomes, or basolateral
membrane [17–22]. These mutants, in contrast to recessive
mutants, are able to heterotetramerize with normal AQP2
protein. The resulting complex is hindered in its transport to the
apical membrane. This process explains the dominant-negative
effect of these mutations. Recently, Mattia et al. found AQP2-
R254L mutation in one allele of a family with dominant NDI
[102]. R254L mutation lacks vasopressin-mediated phosphor-
ylation of AQP2 at Ser256, resulting in its impaired transport to
the cell surface.
The molecular mechanism that impaired AQP2 trafficking
causes NDI suggests a pharmacological strategy for correction
of the sorting in NDI using chemical chaperones [103,104].
However, much work remains to be done before such methods
are available clinically.
Degradation pathway of wild type AQP2 involves both the
proteasomal and lysosomal pathways [105]. Hirano et al.
investigated aspects of the biosynthesis and degradation of the
ER-retained mutant AQP2-T126M and the Golgi apparatus-
retained mutant AQP2-E258K [106]. AQP2-T126M was syn-
thesized as a glycosylated 32-kDa as well as a nonglycosylated
29-kDa form, both of which were rapidly degraded by the
proteasome, albeit a different kinetics. AQP2-E258K was not
exclusively retained in the Golgi apparatus but became mis-
routed to late endosomes/lysosomes and its degradation in-
volved both proteasomes and lysosomes. The final degradative
pathway is different among AQP2 mutants.
Recently, a high prevalence of V168M mutation, which
caused a partial defect in exit from the ER and resulted in partial
NDI, was found in a town in Mexico by the genetic
Fig. 1. Schematic representation of the postulated mechanisms for regulation of
AQP2 trafficking by its binding proteins. AQP2 directly binds to SPA-1, actin,
and the other 11 proteins. Gray column, AQP2; red circle, SPA-1; yellow circle,
G-actin; yellow circles linked, F-actin; green oval, AQP2 binding protein
complex. The depth of blue color in the background indicates the levels of
Rap1GTP: deep blue color indicates relatively high levels of Rap1 GTP, and
light blue color indicates the area where Rap1GTP is decreased. It is speculated
that SPA-1 binding to AQP2 reduces the levels of Rap1GTP that may trigger F-
actin disassembly in a restricted narrow area around AQP2, resulting in the
promotion of the AQP2 sorting. The other 11 proteins which also bind to AQP2
may provide the machinery of driving AQP2 movement.
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an important health care problem in the village.
8. Critical region of AQP2 for its trafficking
Phosphorylation of serine 256 in the cytoplasmic C-terminal
region of AQP2 is important for an apical localization of AQP2
as described above. In addition, mutations located in the C
terminus of AQP2, which are encoded in dominant NDI, cause
AQP2 missorting [17–21]. These findings have shown the
importance of the AQP2 C-terminus for its trafficking. Fur-
thermore, van Balkom et al. showed that region N220-S229,
which was the proximal region of the C terminus of AQP2, was
essential for localization of AQP2 in the apical membrane and
that the N and C termini of AQP2 were essential for trafficking
of AQP2 to intracellular vesicles and its shuttling to and from
the apical membrane [108]. In addition, the sixth transmem-
brane domain of AQP2, including a dileucine motif, is involved
in regulated trafficking of this water channel [109]. These data
suggest the existence of the proteins which interact with these
regions and directly regulate AQP2 trafficking.
9. AQP2-binding protein complex which directly regulate
AQP2 trafficking
Controlled apical positioning of AQP2 suggests the ex-
istence of proteins that recruit AQP2 by binding directly. To
date, several proteins which are localized in AQP2-bearing
vesicles and supposed to mediate its sorting have been reported
as described above, however, proteins that directly interact with
AQP2 and provide specificity in AQP2 sorting have not been
identified. Recently, we have identified for the first time the
AQP2 binding proteins: actin and SPA-1 [110,111]. SPA-1 is a
specific GTPase-activating protein (GAP) for Rap1 and the
GAP activity of SPA-1 is shown to be required for AQP2
trafficking to the apical membrane. These findings are the first
report of direct binding of a channel protein to a GAP and a
cytoskeletal protein actin. In addition, these findings show a
novel role of Rap1GAP family in the regulation of channel
protein sorting.
Rap1 is a Ras-related small GTPase. Rap1 is known to be
implicated in many cellular processes including regulation of
Ras/extracellular-signal-regulated kinase (ERK) signaling path-
way, cell morphogenesis, and cell differentiation [112–114].
Rap1 is also required for cell adhesion and cytoskeletal orga-
nization [115]. In addition, Spine-associated RapGAP (SPAR),
which is homologous to SPA-1, has actin-reorganizing activity
and regulates dendritic spine morphology of neurons via its
GAP and actin-interacting domains [116]. Recently, it is re-
ported that SPA-1 interacts with an actin-binding protein alpha-
actinin [117]. These findings indicate the involvement of Rap1/
SPA-1 signaling in actin cytoskeleton.
It is also reported that Rap1 is involved in cytoskeletal orga-
nization through the crosstalk with other small GTPases in-
cluding Ral and Rho. Active form of Rap1 (Rap1GTP) binds to
Ral guanine nucleotide exchange factors (RalGEFs) [118–120]
that can activate Ral GTPase. RalBP1, one of Ral GTP-bindingproteins, is shown to be a GAP for Rho family GTPases [121],
which participate in the cytoskeletal organization.Moreover, it is
reported that in budding yeast the Rap1 orthologue Bud1 acts
upstream of Rho signaling pathway [122]. Hogan et al. show that
activation of Cdc42, a member of Rho family, rescues the
inhibitory effect of RapGAP on the formation of E-cadherin-
based cell–cell contacts and that overexpression of RapGAP
suppresses the activation of Cdc42, suggesting that Cdc42
functions downstream of Rap1 [123].
Furthermore, recent growing evidence indicates the involve-
ment of Rap1 in trafficking of membrane proteins [123–128].
These findings support the novel mechanism that SPA-1, a GAP
for Rap1, is involved in membrane protein sorting.
As described in “4. Role of the cytoskeleton in AQP2 traf-
ficking”, RhoGTP prevents cAMP-dependent translocation of
AQP2 to the apical membrane by stimulating F-actin polymer-
ization [74,75]. It is speculated that the increase in F-actin
polymerization functions as a barrier for AQP2 sorting to the
apical membrane. Using SPA-1 mutant lacking GAP activity
(LIG-SPA-1) and constitutively active Rap1 mutant (Rap1V12),
we have shown that increase in active form of Rap1 blocks the
apical delivery of AQP2 and GAP activity of SPA-1 is
necessary for the AQP2 trafficking [110]. In addition, dominant
negative Rap1 mutant (Rap1N17), which suppresses the
endogenous Rap1 activity, increases the AQP2 trafficking to
the apical membrane. We are tempting to speculate that Rap1
affects the assembly of F-actin that functions as a barrier for the
AQP2 trafficking between the apical membrane and the
intracellular compartments through the crosstalk with Rho
family GTPases. Thus, SPA-1 binding to AQP2 may decrease
the levels of Rap1 GTP that trigger F-actin disassembly in a
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promotion of the recycling of AQP2 (Fig. 1).
Based on these findings, we have speculated the existence
of a multiprotein complex which includes AQP2, SPA-1 and
actin, for providing the mechanism which generates force and
motion in AQP2 trafficking. We have therefore tried to clarify
the proteins comprising the complex. To isolate a large amount
of proteins which directly bound to AQP2, 100 mg of protein
which was completely solubilized by detergent from the ex-
tract of rat kidney papilla was applied to immunoaffinity
column coupled with anti-AQP2 antibody [129]. The isolated
proteins were analyzed by matrix-assisted laser desorption-
ionization time-of-flight mass spectrometry (MALDI-TOF
MS). In addition to SPA-1 and actin, 11 proteins were iden-
tified using this method: ionized calcium binding adapter
molecule 2, myosin regulatory light chain smooth muscle
isoforms 2-A and 2-B, alpha-tropo myosin 5b, annexin A2 and
A6, scinderin, gelsolin, alpha-actinin 4, alpha-II spectrin, and
myosin heavy chain nonmuscle type A. These proteins have
actin binding ability. It is therefore speculated that each in-
teraction of these proteins in the complex may be dynamic and
this dynamic assembly acts as a key point for the regulation of
the AQP2 trafficking.
These findings are the first report that a multiprotein “force
generator” complex directly binds to a channel protein. This
multiprotein complex may provide the machinery of driving
AQP2 movement. Further studies are required for clarifying
the detail.
Considerable progress has been obtained on the mechanism
of AQP2 trafficking over the past few years. Continued analyses
will reveal detailed molecular insight into the fundamental
physiology of water balance homeostasis and pathophysiology
of water balance disorders.References
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